HomeAI · summaries
Storia in 3 fonti
McKesson strikes $2.25B deal to snap up Precision Medicine Group
McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The healthcare conglomerate ,which ranks eighth on the Fortune 500 list, is set to envelope privately held Precision Medicine Group into its oncology branch as part of an ongoing effort to grow it's high-margin cancer and biopharma businesses.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
McKesson strikes $2.25B deal to snap up Precision Medicine Group
McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The healthcare conglomerate ,which ranks eighth on the…
- ·
benzinga.com
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization - McKesson (NYSE:MCK)
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
